Want to monitor XOMA?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor XOMAxoma has an extensive portfolio of products, programs, and technologies that are the subject of licenses the company has in place with other biotech and pharmaceutical companies. many of these licenses are the result of the company's pioneering efforts in the discovery and development of antibody therapeutics. there are more than 20 such programs that are fully funded by partners and could produce milestone payments and royalty payments in the future.